Donna Ucci

Corporate Officer/Principal presso CORMEDIX INC.

Health Technology

Profilo

Donna Ucci is currently the Senior Vice President & Head-Global Quality at CorMedix, Inc. She started this job in 2022.
Prior to this, she worked as the Vice President-Global Quality Management at Amneal Intermediate, Inc.

Posizioni attive di Donna Ucci

Società	Posizione	Inizio
CORMEDIX INC.	Corporate Officer/Principal	12/05/2022

Tutte le posizioni attive di Donna Ucci

Precedenti posizioni note di Donna Ucci

Società	Posizione	Fine
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Donna Ucci

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Donna Ucci

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CORMEDIX INC.	Health Technology

Aziende private	1
Amneal Intermediate, Inc. Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.	Health Technology